Management of Serotonin Syndrome

Diagnosis

• The diagnosis of serotonin syndrome can be confirmed using the Hunter Criteria, which require the presence of a serotonergic agent plus one of the following: spontaneous clonus, inducible clonus with agitation or diaphoresis, ocular clonus with agitation or diaphoresis, tremor and hyperreflexia, or hypertonia, temperature above 38°C, and ocular or inducible clonus 1

Clinical Presentation

• Serotonin syndrome presents as a clinical triad of mental status changes, autonomic hyperactivity, and neuromuscular abnormalities, including agitation, confusion, delirium, hyperthermia, tachycardia, hypertension, diaphoresis, clonus, hyperreflexia, myoclonus, rigidity, and tremor 1

Management Algorithm

• Severe serotonin syndrome is characterized by hyperthermia, muscle rigidity, and multiple organ failure, and requires aggressive management, including ICU admission, aggressive cooling measures, benzodiazepines for sedation, and consideration of intubation and paralysis in cases with severe rigidity and hyperthermia 1
• The American Academy of Pediatrics recommends aggressive cooling measures for hyperthermia in severe serotonin syndrome 2

Important Considerations

• The mortality rate for serotonin syndrome is approximately 11%, emphasizing the importance of prompt recognition and treatment, according to the American College of Medical Toxicology 1
• Benzodiazepines are first-line agents for agitation and neuromuscular symptoms in serotonin syndrome, as recommended by the American Academy of Pediatrics 2